JBJaryd Bourke

Jaryd Bourke

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Jaryd Bourke has a total of 80 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Exploring the digital landscape: A scoping review of Achilles tendinopathy education on public websites and in randomised controlled trials

    by Peter Malliaras, Adrian Mallows, Sean McAullife, Ruth L Chimenti, Wenbo Chen, Jie Deng, Jinjian Jiang, Shivam Sharma, Morgan Potter, Hayley Smitheman, et al.

    Objectives: The aims of this scoping review were to (i) map education from randomised controlled trials and public websites for Achilles tendinopathy to pre-defined categories and (ii) appraise the quality of education available. Data sources: Sources were extracted via a search of multiple databases and from the first three pages of targeted Google searches in English, Chinese, and Spanish (websites). Review methods: The frequency of sources that reported on each pre-defined category (n = 15) was reported, and the content within each category was summarised descriptively. Quality and reliability were assessed with the DISCERN tool (1–5 points, higher score means higher quality and trustworthiness). Understandability and actionability of education was assessed using Patient Education Materials Assessment tool (0–100%, higher scores indicate more comprehensible information with clearer messages and more identifiable actions). Alignment with current international guidelines was reported. Results: 119 randomised controlled trials and 385 websites were included. Education coverage was better in websites compared to trials, particularly related to pathology and management. Conflicting advice was found on websites (e.g. when treatment should be sought). Quality (1.6 ± 0.5) and reliability (2.1 ± 0.7) of education were poor, with low scores for treatment risks and shared decision-making. Understandability was moderate (59%) and actionability was poor (28%). Alignment with clinical guidelines was low, with key information commonly omitted. Conclusion: Educational sources found in randomised controlled trials and public websites on Achilles tendinopathy are poorly aligned with clinical guidelines. The information gaps in these sources mean that they are unhelpful to patients and may steer them towards inappropriate decisions. The review highlights the need for the development of accurate, meaningful, and evidence-based educational resources for individuals with Achilles tendinopathy.

  • Open Access

    Does radial shockwave therapy lead to immediate improvements in pain in people with insertional Achilles tendinopathy? A randomised controlled trial

    by B Alsulaimani, L Perraton, J Bourke, T Powers, P Malliaras

    Objectives: To investigate the immediate effects of radial shockwave therapy versus sham on movement evoked pain in people with insertional Achilles tendinopathy. Design: Randomised controlled trial. Setting: Private clinic. Participants: People diagnosed with insertional Achilles tendinopathy who were over 18 years old with a symptom duration of greater than 3 months. Intervention: Seventy-six participants (53% female, mean age 51 years) were randomly allocated to a radial shockwave (n = 38) or sham (n = 38) group. Three sessions of radial shockwave or sham (no pressure) to the most affected side in 5-to-10-day intervals. All participants received identical education and exercises. Main measures: The primary outcome measure was movement evoked pain (measured on a 100 mm visual analogue scale) at the first, second and third session immediately after each application. Results: There was 96% follow up of participants at the third session. Over half of the participants believed they were receiving the ‘real’ treatment (average 58%). The mean movement evoked pain scores improved each session by 0.6 points for the radial shockwave therapy and 0.7 points for the sham group. There was no difference between the groups after the first (−0.4, 95% confidence interval (CI) −1.6 to 0.8), second (0.4, 95% CI −0.8 to 1.6) or third session (−0.4, 95% CI −1.6 to 0.8). Conclusions: In adults with insertional Achilles tendinopathy, radial shockwave therapy demonstrated no more efficacy than a sham in reducing immediate movement evoked pain. These results do not support the use of radial shockwave therapy for immediate pain relief among people with this condition. Clinical trial registration: ACTRN12620000035921.


  • Diagnostic domains, differential diagnosis and conditions requiring further medical attention that are considered important in the assessment for Achilles tendinopathy: a Delphi consensus study

    by Peter Malliaras, Karin Gravare Silbernagel, Robert-Jan de Vos, Jaryd Bourke, Igor Sancho, Shawn L Hanlon, Anne-Sofie Agergaard, Roald Bahr, Natália Franco Netto Bittencourt, Marcelo Bordalo, et al.

    The absence of agreed methods to diagnose Achilles tendinopathy impedes research and clinical practice. This gap results in heterogeneous and/or poorly described study samples, making it challenging to apply findings in clinical practice. The aim of this Delphi study was to define consensus on (1) diagnostic domains; (2) differential diagnoses; and (3) conditions requiring further medical attention, when assessing for Achilles tendinopathy. We conducted a sequential three-stage process which included: (1) identifying diagnostic domains, differential diagnoses and conditions requiring further medical attention based on existing scoping reviews and clinical practice guidelines; (2) developing Delphi survey questions; and (3) administering a five-round Delphi online survey. Consensus was defined as ≥70% agreement. 52 participants completed the surveys. Four diagnostic domains were deemed essential and reached consensus (pain location (93%); pain during activity (97%); tests that provoke pain (87%); palpation to assess pain (83%)). 15 differential diagnoses reached consensus: 2 for both midportion and insertional (partial tear (80%); posterior ankle impingement (78%)), 6 for midportion (plantaris tendinopathy (84%); tibialis posterior or flexor hallucis longus tendinopathy/tenosynovitis (72%); flexor digitorum longus tendinopathy (77%); accessory soleus muscle (74%); paratendinopathy (86%); sural nerve neuropathy (81%)) and 7 for insertional (superficial (88%) and retrocalcaneal bursitis (86%); Haglund’s/calcaneal exostosis (80%), intratendinous calcifications (73%); Sever’s disease (78%); calcaneal stress reaction/fracture (80%); subtalar/ankle pain (71%)). Six conditions requiring further medical attention reached consensus: (Achilles tendon rupture (83%); systemic inflammatory joint disease (86%); metabolic syndrome (75%); familial hypercholesterolaemia (77%); endocrine and hormonal disorders (80%); drug reactions (77%)). This consensus identified essential diagnostic domains, differential diagnoses and conditions requiring further medical attention that should be considered when assessing for Achilles tendinopathy.


  • Open Access

    Efficacy of heel lifts for insertional Achilles tendinopathy (LIFTIT): A randomised feasibility trial

    by Jaryd Bourke, Shannon Munteanu, Alessandro Garofolini, Simon Taylor, Peter Malliaras

    Objectives: Insertional Achilles tendinopathy is a common and disabling condition. This trial aimed to determine the feasibility of conducting a parallel group randomised trial to evaluate the efficacy of heel lifts compared to a sham intervention for reducing pain intensity associated with insertional Achilles tendinopathy.Methods: Twenty‐six people with insertional Achilles tendinopathy were randomised to either the heel lift group or sham intervention group. Outcome measures were obtained at baseline, 4, 8 and 12 weeks. The primary outcome was feasibility, evaluated according to demand (recruitment rate and conversion rate), acceptability, adherence, adverse events and retention. Limited efficacy testing was conducted on secondary outcome measures including pain intensity, function, physical activity, health‐related quality of life, use of co‐interventions and global rating of change.Results: Between August 25, 2023, and April 7, 2024, we recruited and tested 26 participants (aged 28–65 years, mean [SD] 51 [8]). The pre‐determined thresholds were met for demand, acceptability, adherence, retention, pain intensity, function, quality of life and global rating of change and partly met for adverse events, physical activity and use of co‐interventions. Between 47 and 241, participants will be needed for a fully powered randomised trial.Conclusion: In its current form, a randomised trial of heel lifts compared to a sham intervention is feasible. However, future triallists may need to consider strategies to manage the risk of adverse events and plan to adjust the analyses to account for the use of co‐interventions.Trial registration: ACTRN12623000721606.


  • Open Access

    Efficacy of heel lifts for lower limb musculoskeletal conditions: A systematic review

    by Jaryd Bourke, Shannon Munteanu, Eman Merza, Alessandro Garofolini, Simon Taylor, Peter Malliaras

    Introduction: The objective of this systematic review is to determine the benefits and harms of heel lifts to any comparator for lower limb musculoskeletal conditions.Methods: Ovid MEDLINE, Ovid AMED, Ovid EMCARE, CINAHL Plus and SPORTDiscus were searched from inception to the end of May 2024. Randomised, quasi‐randomised or non‐randomised trials comparing heel lifts to any other intervention or no‐treatment were eligible for inclusion. Data was extracted for the outcomes of pain, disability/function, participation, participant rating of overall condition, quality of life, composite measures and adverse events. Two authors independently assessed risk of bias and certainty of evidence using the GRADE approach at the primary time point 12 weeks (or next closest).Results: Eight trials (n = 903), investigating mid‐portion Achilles tendinopathy, calcaneal apophysitis and plantar heel pain were included. Heel lifts were compared to exercise, ultrasound, cryotherapy orthotics, stretching, footwear, activity modification, felt pads and analgesic medication. No outcome was at low risk of bias and few effects (2 out of 47) were clinically important. Low‐certainty evidence (1 trial, n = 199) indicates improved pain relief (55.7 points [95% CI: 50.3–61.1], on a 100 mm visual analogue scale) with custom orthotics compared to heel lifts at 12 weeks for calcaneal apophysitis. Very low‐certainty evidence (1 trial, n = 62) indicates improved pain and function with heel lifts over indomethacin (35.5 points [95% CI: 21.1–49.9], Foot Function Index) at 12 months for plantar heel pain.Conclusions: Few trials have assessed the benefits and harms of heel lifts for lower limb musculoskeletal conditions. Only two outcomes out of 47 showed clinically meaningful between group differences. However, due to very low to low certainty evidence we are unable to be confident in the results and the true effect may be substantially different.Registration: PROSPERO registration number CRD42022309644.


  • Use of Behavior Change Techniques Alongside Exercise in the Management of Rotator Cuff–Related Shoulder Pain: A Scoping Review

    by Jaryd Bourke, Helen Skouteris, Kostas Hatzikiriakidis, David Fahey, Peter Malliaras

    Objectives: The aims of this scoping review were to: (1) determine the frequency and types of behavior change techniques (BCTs) and education utilized in trials investigating exercise interventions for rotator cuff related shoulder pain (RCRSP); (2) subcategorize the BCTs and education found in the trials to summarize all behavior change approaches reported by trials; and (3) compare the frequency, types, and subcategories of BCTs and education utilized in the clinical guidelines for managing RCRSP between the trials.Methods: Data sources included Cochrane Central Register of Controlled Trials, Ovid MEDLINE, Ovid EMBASE, CINAHL Plus, Google Scholar and PubMed, which were searched from inception to June 2020. Trials assessing exercise interventions for RCRSP were included. Three authors independently determined eligibility and extracted data. The frequency and types of BCTs and education in the trials and clinical practice guidelines were reported and compared descriptively. Two authors assessed the content of the BCTs to develop subcategories.Results: Most trials reported including at least 1 type of BCT (89.2%), which was most commonly feedback and monitoring (78.5%). There were many different approaches to the BCTs and education; for example, feedback and monitoring was subcategorized into supervised exercise, exercise monitoring, and feedback through external aids, such as mirrors. Clinical guidelines recommend supervision, goal setting, activity modification, pain management recommendations, information about the condition, and exercise education.Conclusion: Although over two-thirds of trials reported including a BCT alongside exercise interventions for RCRSP, the breadth of these interventions is limited (supervision is the only common one). Future trialists should consider using any type of BCT that may improve exercise adherence and outcomes.Impact: The findings of this review have: (1) identified gaps in the literature; and (2) contributed to the design of future exercise interventions for RCRSP.